Afqlir (aflibercept), a 2 mg pre-filled syringe for intravitreal injection developed by Sandoz, is now available in Australia.
Data from SeeWay has highlighted the critical importance of early, lifestyle-focussed support for patients adjusting to vision loss.
A fundamental transformation in the way health data is managed is needed if Australia is to meet the health challenges of an ageing population,
Positive results have been reported from a study using both optical coherence tomography (OCT) and full-field electroretinogram (ffERG) testing to evaluate the efficacy and
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
